Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial
BeiGene
Peter Hillmen; Barbara Eichhorst; Jennifer R Brown; Nicole Lamanna; Susan M O'Brien; Constantine S Tam; Lugui Qiu; Maciej Kazmierczak; Keshu Zhou; Martin Šimkovič; Jiří Mayer; Amanda Gillespie-Twardy; Mazyar Shadman; Alessandra Ferrajoli; Peter S Ganly; Robert Weinkove; Sebastian Grosicki; Andrzej Mital; Tadeusz Robak; Anders Österborg; Habte A Yimer; Tommi Salmi; Meng Ji; Jessica Yecies; Adam Idoine; Kenneth Wu; Jane Huang; Wojciech Jurczak